Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Tenet Healthcare Corporation (THC)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
55.50-1.37 (-2.41%)
At close: 04:00PM EDT
55.50 +0.25 (+0.45%)
After hours: 04:04PM EDT
Advertisement
Sign in to post a message.
  • R
    Richard Nguyen
  • J
    JAMES
    $FCGD conversation
    $FCGD is happy to announce its subsidiary company Green Diamonds Llc. first grow license has been initially approved by the state of MI. We will work at a steady pace to get licenses approved to set up facilities around Michigan and other states for distribution. #cannabis #THC #CBD #cannabiscommunity #cannabisculture #marijuana
  • J
    JAMES
    $FCGD conversation
    Breaking News! Fine Cannabis Goods Corp has partnered with Michigan-based communications group Sygnifi Networks https://bit.ly/3z4CcmR who is now working behind the scenes on
    our digital marketing and SEO needs. $FCGD #cannabis #THC #CBD #cannabiscommunity #cannabisculture #marijuana

    https://twitter.com/corp_fine/status/1531670665308299264?s=21&t=aSGPE7Bz6HBm57ZdXk67Wg
  • B
    Bob
    Does THC have quality facilities. ie Compared to HCA?
  • D
    Don
    Deutsche Bank has THC as a buy with tgt of $110, Citigroup a buy, Barkleys overweight, PBC Capitol Outperform with tgt of $104. Go figure.
  • A
    Anonymous
    50's COMING!!!! OUCH!!!!!!!!!
  • A
    Anonymous
    LOLOLOL - KARMA AGAIN!! Cybersecurity incident. You don't say!!!?? And why are we not releasing details of the incident?? Hmmmmm....
  • C
    Charles
    Apparently their presentation at the Goldman Sachs conference did not go well.
  • Y
    Yahoo Finance Insights
    Tenet Healthcare is down 6.54% to 81.00
  • Y
    Yahoo Finance Insights
    Tenet Healthcare is down 5.57% to 84.05
  • Y
    Yes or No
    Roilty now on sale.

    Congrats to our CannMart Labs team for launching the first round of “Roilty” products on CannMart Marketplace!

    For cannabis extract enthusiasts and legacy consumers alike, “Rolity” offers a selection of exciting and interesting strains, with extra care in the curation and extraction process. We place value on preserving high terpene profiles which results in rich, flavourful concentrates.

    The first two 2.0 cartridge products to hit the market by “Roilty” are: Henry the Grape Ape (indica) & Hawaiian Thunder Queen (sativa).

    Find the Products here:

    https://lnkd.in/gCHhgsB

    #cannabis #cannabisculture #cannabisindustry #cartridge #thc #ecommerce #marketplace-front
    Created by CannMart Labs
    Created by CannMart Labs
    lnkd.in
  • W
    Winorlose
    $9 BB CAP, nooo thanks! Must be huge debts too
  • D
    Donny
    $THC.CN conversation
    April, May, June...this discount price will not last much longer, buy while you can!!! $THC price target $5 by end of 2018.
  • E
    E.E
    Genprex, Inc.
    Good Friday to all true LONGS.....I hope you and yours are safe and healthy. I just want to share info only......I am heavily invested in a few companies, especially these 4. First, Gene therapy is huge. Genprex is a biotech gene therapy company. Its miracle Oncoprex drug is potentially a blockbuster gene therapy drug in treating lung, thyroid, glioblastoma, breast, kidney and many other Unknown cancer treatment benefits. Genprex also signed an exclusive agreement with UPMC Dr. Gittes and team. Its gene therapy treatment in combination with Dr. Gittes findings in treatment for diabetes type 1 & 2. I provided my detailed research information and my calculation for its FDA fast track lung cancer & diabetes PT in my previous posts. This is my 2-3 years investment........... Second, Decision Diagnostics Corp. is the fastest (15 seconds) & accurate GenViro COVID-19 swift test kit, utilizing antibody/antigen methodology. It has received Pre-EUA acknowledgment letter & product S/N from the FDA. This stock is potentially be huge in near to immediate term. I think FDA approval is very soon............Third, Cytodyn's Leronlimab drug positive results in treating as muchas (15) EIND covid-19 patients & plan to conduct more EIND critical ill COVID-19 patients. They are currently conducting its COVID-19 trial 2b/3 earlier this week for severely ill COVID-19, for 342 patients. They are also conducting Randomized trial 2, which started March 31st, for 75 patients. They also received FDA fast track for its HIV & Cancer treatments. I think FDA approval once these 2 trials complete Or a bit sooner due to pandemic situation........ Fourth, Oragenics Inc developed AG013, an oral mucositis in cancer treatment. Its 2nd phase readout is planned in early 2nd Quarter 2020 (anyday now)....... Do your DD before investing. Stay safe & Good cheers to all true longs. $GNPX, $DECN, $CYDY, $OGEN, $AIM, $THC, $NIO
    Bullish
  • j
    jerry
    THC has been in a steady uptrend since the earnings report. I fully expect the price to rise to $34 by the end of next week.
  • M
    MP
    $TNY.CN conversation
    Tinley’s Beverage Co. @drinktinleys
    More Grapefruit-Blue Agave-Lime #cocktail-inspired sparkling #thc #beverages on the way…each with a #microdose of #EmeraldTriangle #cannabis and #pineapplejack #sativa #terpenes, completely #nonalcoholic $TNY $TNYBF #vegan #glutenfree Only 5g sugar. Order online in #California
    https://twitter.com/drinktinleys/status/1427767678731792391?s=21&fbclid=IwAR0_lB_0tORgIOmBbutBfsbcTz3jVmnBj0l4nbalxiuAU4E0twA4nYIee3k
  • j
    jenenifer
    This company has an outstanding and savvy CEO. His management over the past 2 to 3 years has turned the company around!!! The stock price has significantly appreciated and the market has recognized his hard work. I hope those working for this company have taken notice and participated in the Employee Stock Purchasing Program.
Advertisement
Advertisement